About Ascential Technologies
Ascential Technologies is a Healthcare company based in Kent City (United States) founded in 1953, and was acquired by AEA Investors in August 2022. Automation solutions are provided for medical and life sciences manufacturing. Its chief executive, as recorded, is Jeff Moss. Its website ascentialtech.com draws about 11 thousand monthly visits. Ascential Technologies offers products and services including Automation Solutions, Testing Equipment, and Diagnostics Systems. Its focus areas include Biopharma Outsourcing and Diversified. Its competitors include ANI Pharmaceuticals, Red Nucleus and Aptar.
Company details
Ascential Technologies was founded in 1953 and is headquartered in Kent City, United States. Operations focus on automation machinery for the medical and life sciences sector. End-to-end solutions are delivered for complex product lifecycles by a team exceeding 2,300 experts. Reshoring efforts in medical and life science manufacturing have been supported through a new facility.
- Headquarters Kent City, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website ascentialtech.com
- Social LinkedIn X Facebook
- Acquired by AEA Investors (Aug 2022)
- Investors
- Acquired byAEA Investors
(Aug 2022)
Products & Services of Ascential Technologies
Ascential Technologies offers a comprehensive portfolio of products and services, including Automation Solutions, Testing Equipment, and Diagnostics Systems.
Delivers custom automation for medical devices and processes
Provides systems for vehicle and industrial quality testing
Offers inspection tools for transportation and life sciences
Investors in Ascential Technologies
Ascential Technologies has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include AEA Investors.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity and debt firm focused on mid-market companies | aeainvestors.com | New York, United States |
Investor details for Ascential Technologies
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Ascential Technologies
21 people are tracked at Ascential Technologies (18 in leadership, 3 in team).
| Name | Role | Group |
|---|---|---|
Daniel Webber | Managing Director | Leadership |
Jeff Moss | CEO | Leadership |
Charles An | Managing Director | Leadership |
Kevin Peake | Director Of Business Development | Leadership |
Ben Willms | Director of Business Development | Leadership |
Bob Taplin | Senior Director Business Development | Leadership |
Georgette Dulworth | Chief Legal Officer | Leadership |
Melissa Detamble | Chief Human Resources Officer | Leadership |
David Banish | Cfo, Specialty Industrial - North America | Leadership |
Leah Nakfoor | Director Of Business Operations | Leadership |
Ward van de Walle | Vice President General Industry | Leadership |
Erica Wasson | VP Human Resources- Medical Life Sciences Division | Leadership |
Georgette Borrego Dulworth | Chief Legal Officer | Leadership |
Benjamin S. | Sr Director, IT Test & Measurement | Leadership |
Erin Holmes Dillard | Chief Commercial Officer (cco) | Leadership |
Brunno Moretti | President - ADAS Solutions | Leadership |
Anthony Valera | Director, Business Development | Leadership |
Chelsie Brecht | Director, Marketing | North America | Leadership |
Darryl Zook | Senior Software Controls Engineer | Team |
John Huisinga | Senior Manager, People Processes | Team |
1 more people are available in the full profile.
Complete people profiles for Ascential Technologies
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Ascential Technologies
2 dated milestones of Ascential Technologies across 69 years, from founding to its latest funding, stage changes and deals.
- Founded Ascential Technologies is founded.
- Exit Acquired by AEA Investors.
Competitors of Ascential Technologies
Ascential Technologies has 3 listed competitors in our database. They include ANI Pharmaceuticals, Red Nucleus and Aptar.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| anipharmaceuticals.com | 1996 | Baudette, United States | 600 | Branded and generic prescription drugs are developed, manufactured, and marketed. | ||
| rednucleus.com | 2014 | Yardley, United States | 176 | Advisory, scientific, and medical communications provided for pharmaceutical industry. | ||
| aptar.com | 1992 | Crystal Lake, United States | 232 | Regulatory support, brand differentiation, and prototyping services are provided. |
Detailed competitors of Ascential Technologies
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Ascential Technologies
The website of Ascential Technologies (ascentialtech.com) receives about 10.9K visits a month.
- Monthly visits10.9K
▼ 3.2% vs previous month
Websites whose visitors overlap most with Ascential Technologies. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| agapeplastics.com | 100% | 680.7K | #5,409,734 | View details | |
| havilandusa.com | 88% | 2.8K | #5,131,907 | View details | |
| americhem.com | 76% | 8K | #2,577,539 | View details | |
synthealth.com | synthealth.com | 42% | #1,209,105 | – | |
taltech.com | taltech.com | 41% | #1,315,706 | – |
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Ascential Technologies (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Ascential Technologies
Complete news archive for Ascential Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ascential Technologies
Ascential Technologies was founded in 1953.
Ascential Technologies is headquartered in Kent City, United States. It is registered at Kent City, Michigan, United States.
Jeff Moss is the CEO of Ascential Technologies, as recorded in our data.
Ascential Technologies was founded in 1953 and is headquartered in Kent City, United States. Operations focus on automation machinery for the medical and life sciences sector. End-to-end solutions are delivered for complex product lifecycles by a team exceeding 2,300 experts. Reshoring efforts in medical and life science manufacturing have been supported through a new facility.
Ascential Technologies's top competitors include ANI Pharmaceuticals, Aptar and Red Nucleus.
Ascential Technologies offers Automation Solutions, Testing Equipment, and Diagnostics Systems.
Ascential Technologies has 1 investor. Key investors include AEA Investors.
Yes. Ascential Technologies was acquired by AEA Investors in August 2022.